跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rylin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rylin
Approved
STANDARD
Rylin
NCPC Hebei Huamin Pharmaceutical Co., Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e4f061417e01374e
Company
NCPC Hebei Huamin Pharmaceutical Co., Ltd
Type
Standard
Approval Details
Approval Id
e4f061417e01374e
Drug Approval Philippines Name
Rylin
Product Name
Rylin
Registration Number
DRP-8075-03
Brand Name
Rylin
Generic Name
Cefazolin (as sodium)
Dosage Form
Powder for Injection (IM/IV)
Dosage Strength
1 g
Manufacturer
NCPC Hebei Huamin Pharmaceutical Co., Ltd
Importer
Aglobal Care, Inc.
Distributor
Tamiga Pharmaceuticals Supply
Issuance Date
25 March 2024
Expiry Date
18 May 2028
Pharmacologic Category
Antibacterial (First Generation Cephalosporin)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e4f061417e01374e
Type
Standard
Back to Philippines FDA Approvals